The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma

PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide and irinotecan for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGNS: Seventy five patients with newly diagnosed glioblastoma were enrolle...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Vredenburgh, James J., Desjardins, Annick, Reardon, David A., Peters, Katherine B., Herndon, James E., Marcello, Jennifer, Kirkpatrick, John P., Sampson, John H., Bailey, Leighann, Threatt, Stevie, Friedman, Allan H., Bigner, Darell D., Friedman, Henry S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2011
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117928/
https://ncbi.nlm.nih.gov/pubmed/21531816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0120
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια